Tech Company Financing Transactions
Amberstone Biosciences Funding Round
On 1/7/2022, Amberstone Biosciences landed $12 million in Series A funding from Co-win Healthcare Fund, Sinovation Ventures and Viva Ventures Biotech.
Co-win Healthcare Fund (Lead Investor) (Xin Huang)
Sinovation Ventures (Lead Investor) (Peter Wu)
Viva Ventures Biotech (Lead Investor) (Han Dai)
Laguna Hills, CA 92653
Browse more venture capital transactions:
Prev: 1/7/2022: Finexio venture capital transaction
Next: 1/7/2022: Eikon Therapeutics venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record tech company VC transactions. All VC database entries reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs